Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. - Zhu,Q.; Barakat,B.M.; Wani,G.; Zhao,Q.; El-Mahdy,M.A.; Wani,A.A. (Cancer Res, 2009)